Please select the option that best describes you:

When would you administer the next maintenance dose of rituximab in a patient with ANCA glomerulonephritis who last received an infusion six months ago and has low immunoglobulin levels and an undetectable CD-19 cell count?  



Answer from: at Academic Institution
Sign in or Register to read more